A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Sheba Medical Center, Ramat Gan, Central District, Israel

Hadassah Medical Center, Jerusalem, Israel

Brigham And Womens Hospital, Boston, Massachusetts, United States

Duke University, Durham, North Carolina, United States

Local Institution - 0007, Camperdown, New South Wales, Australia

Local Institution - 0008, Brisbane, Queensland, Australia

Local Institution - 0013, Clayton, Victoria, Australia

Local Institution - 0040, Salvador, Estado de Bahia, Brazil

Local Institution - 0039, Porto Alegre, Brazil

Local Institution - 0038, São Paulo, Brazil

Local Institution - 0004, Prague, Praha 5, Czechia

Revmatologicky ustav, Prague, Czechia

CHU Strasbourg-Hautepierre, Strasbourg, Alsace, France

Hopital Claude Huriez - CHU de Lille, Lille, Nord, France

Universitaetsklinikum Duesseldorf, Düsseldorf, North Rhine-Westphalia, Germany

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel, Schleswig-Holstein, Germany

Charité - Universitaetsmedizin Berlin - Campus Bejnamin Franklin, Berlin, Germany

Universitätsklinikum Carl Gustav Carus an der TU Dresden, Dresden, Germany

Local Institution - 0031, Hamburg, Germany

Uniwersyteckie Centrum Kliniczne, Gdansk, Pomeranian Voivodeship, Poland

Szpital Specjalistyczny nr 1 w Bytomiu, Bytom, Silesian Voivodeship, Poland

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy w Gliwicach, Gliwice, Silesian Voivodeship, Poland

Local Institution - 0017, Lodz, Łódź Voivodeship, Poland

ARENSIA Exploratory Medicine, Cluj-Napoca, Cluj, Romania

Fundeni Clinical Institute, Bucharest, Romania

Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, Catalunya [Cataluña], Spain

Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad de, Spain